Clinical Trials Logo

Hearing Loss, Sensorineural clinical trials

View clinical trials related to Hearing Loss, Sensorineural.

Filter by:

NCT ID: NCT03595163 Enrolling by invitation - Propofol Clinical Trials

Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To investigate the effect of sevoflurane and propofol on the concentrations of serum homocysteine and folic acid in children who received cochlear implant surgery.

NCT ID: NCT03582566 Completed - Clinical trials for Hearing Loss, Sensorineural

Training Language and Literacy for Children Who Use CIs

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

This study aims to determine the effectiveness of computer games to improve language and literacy outcomes for children who have hearing loss. Children will be assigned to one of four conditions: phonological awareness training, working memory training, phonological awareness + working memory training, or active control.

NCT ID: NCT03555084 Completed - Clinical trials for Hearing Loss, Sensorineural

Quality Control of CE-Certified Phonak Hearing Aids - 2018_07

Start date: May 22, 2018
Phase: N/A
Study type: Interventional

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

NCT ID: NCT03512951 Completed - Clinical trials for Hearing Loss, Sensorineural

Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception

EXTEND
Start date: October 9, 2018
Phase: N/A
Study type: Interventional

Within the course of this study, a signal processing feature has been developed at Ecole Polytechnique Fédérale de Lausanne (EPFL), in collaboration with Sonova AG, in order to enhance the listening experience with remote microphone systems. In particular, the developed feature is supposed to improve the so-called audio-visual fusion, i.e. the fact to perceive the sound as coming from the physical location of the source. One of the main goals of the present study is to evaluate the extent to which this feature reaches that objective.

NCT ID: NCT03509974 Completed - Clinical trials for Unilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis)

Early Experience of a New Implant System for Bone Conduction Hearing in the Pediatric Population

OSIA Pediatric
Start date: April 18, 2018
Phase: N/A
Study type: Interventional

To study the initial experience with implanting and fitting a new Bone Conduction system in pediatric patient population with conductive, mixed or single-sided deafness.

NCT ID: NCT03500718 Completed - Clinical trials for Cochlear Hearing Loss

Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation

Start date: February 26, 2018
Phase: N/A
Study type: Interventional

After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).This ECAP is measured intra operatively, after 4 weeks( at switch on), after 3months and 6 months following cochlear implantation.

NCT ID: NCT03467399 Completed - Clinical trials for Sensorineural Hearing Loss

Clinical Evaluation of a Cochlear Implant System

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the usability of a Cochlear implant system.

NCT ID: NCT03402932 Completed - Clinical trials for Cognitive Impairment

Administration Method of Cognitive Screening in Older Individuals With Hearing Loss

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The objectives of the current project aim to determine whether a more controlled amplification method or a visual administration has an effect on hearing impaired older individuals' cognitive test scores.

NCT ID: NCT03382769 Terminated - Clinical trials for Hearing Loss, Sensorineural

Hearing Loss in Older Adults Study

Start date: March 27, 2019
Phase: N/A
Study type: Interventional

This is a prospective, 1:1 randomized controlled trial of immediate versus delayed cochlear implantation (CI) on hearing handicap, communicative function, loneliness, mental wellbeing, and cognitive functioning. Participants are randomized 1:1 to an immediate cochlear implant intervention group versus a hearing aid control intervention.

NCT ID: NCT03379870 Active, not recruiting - Clinical trials for Hearing Disorders in Children

Outcomes in Children With Pre-operative Residual Hearing

Start date: May 25, 2018
Phase: N/A
Study type: Interventional

Purpose: Routine clinical care and pilot study data has shown evidence of postoperative hearing preservation in pediatric cochlear implant (CI) recipients. The primary aim of this study is to investigate speech perception performance in pediatric CI recipients with functional pre-operative hearing. Participants: Two cohorts of CI recipients aged 6 through 17 years who had pre-operative low frequency residual hearing. Subjects in Arm 1 will present with a post-operative low frequency pure tone average (125, 250, and 500 Hz) of ≤ 75 dB HL, and those in Arm 2 will present with a post-operative low frequency pure tone average (LFPTA) that exceeds 75 dB HL. Procedures (methods): Subjects will complete speech perception and quality of life testing during post-operative intervals. Subjects in Arm 1 will be evaluated with the hearing aid alone (HA-alone) and with combined electric-acoustic stimulation (EAS). Subjects in Arm 2 will be evaluated with the CI-alone.